The FDA announced today that a Philips recall involving remote cardiac monitoring software is Class I, its most serious recall designation.

The Food and Drug Administration announced that Philips recalled the software following 109 reported injuries and two ...

The FDA is elevating a recall from Philips related to one of its wearable outpatient heart monitors, used to help detect ...

Philips' smart systems and intelligent software showcased at Arab Health 2025 is developed to enable predictability, collaboration, precision, and integration to deliver better care for more people ...

Some electrocardiogram events, such as atrial fibrillation or abnormally rapid heartbeats, over two years were not reviewed ...

At least two deaths and over a hundred injuries have been linked to a malfunctioning heart monitoring device from Philips and its subsidiary, Braemer. The company affirmed in a statement that that the ...

NEWS - A Philips device that heart patients can attach to their chests so their heart rate can be monitored from home by ...

The Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation ...

Philips recalls software for mobile cardiac telemetry devices after patient injuries and deaths. Urgent medical device correction issued. Class I recall.

Another 109 people reported injuries after using the remote cardiac monitoring software, Modern Healthcare reported. Other pharmaceutical and tech news is on the FDA's drug approval system and a rapid ...

Philips’ application software for outpatient monitoring is used to analyze, display and report symptomatic and asymptomatic cardiac events in ECG data received from devices. The data is then ...